CureZone
Old Format -> CureZone.INFO
Re: Chitin Synthesis Inhibitor.
Forum: The Candida Diet  
  • Chitin Synthesis Inhibitor.   #173936   16mo  4,194
    • Can you point me to where it’s mentioned?   Dr.Jeff   16mo  3,618
      • It is on the natural news website as an add n...   #173936   16mo  3,513
        • Okay, I’ll look for it.   Dr.Jeff   16mo  3,593
          • http://candidacleanser.com/sl.html   #173936   16mo  3,778
            • I think you’re talking about lufenuron, Dr. w...   Artiksus   16mo  3,627
              •   Here’s some info on Lufenuron: ... ...   ...   RRR Educational Dr.Jeff   16mo  13,389  
                This is my avatar. Click here to see my profile.
                Dr.Jeff
                Date: 8/22/2013 11:21:24 AM   ( 16mo ago )   Hits:   13389

                 Here's some info on Lufenuron:

                 

                LUFENURON

                 

                Lufenuron is approved for use in dogs and cats 6 weeks of age and older for the control of flea populations.

                 

                Lufeneron showed initial promise as a treatment for fungal infections, but the earlyenthusiasm has dampened considerably as efficacy appears doubtful.

                 

                Lufenuron acts by inhibiting chitin synthesis, polymerization, and deposition in fleas, thereby preventing eggs from developing into adults. It is believed that lufeneron’s nonspecific effect on chitin synthesis is related to serine protease inhibition. Lufeneron’s mechanism of action, theoretically, would also have effect on fungi.

                 

                Adverse effects reported in dogs and cats after oral lufenuron include: vomiting, lethargy/depression, pruritus/urticaria, diarrhea, dyspnea, anorexia, and reddened skin. The manufacturer reports that the adverse reaction rate is less than 5 animals in one million doses.

                http://www.scribd.com/doc/72234998/76/LUFENURON

                  

                Chitin is found in the supporting structures of many organisms. Of relevance to microbiology, chitin is present in fungal species such as mushrooms, where it can comprise from 5% to 20% of the weight of the organism.

                http://www.enotes.com/chitin-reference/chitin

                 

                orally-administered pills can sometimes cause an upset stomach with acid reflux.

                 

                Lufenuron is thought to be an effective anti-fungal in plants. It is safe because Lufenuron is biochemically inert to mammals. Lufenuron is not broken down by the liver or kidneys.Lufenuron's antifungal property may be due to its inhibiting the synthesis of chitin, which makes up roughly 33% of the typical fungal cell wall.

                Lufenuron was included in a biocide ban proposed by the Swedish Chemicals Agency because it is toxic to fresh water zooplankton [1] and approved by the European Parliament on January 13, 2009.[2]

                Wiki

                 

                Chitin synthesis inhibitors share a similar chemical structure as other benzoylphenyl ureas.Their mode of action is by interfering with the polymerization pathway of chitin, inducing accumulation of the monomer uridine diphospho-N-acetylglucosamine and blocking its synthesis (Beeman 1982).

                http://ddr.nal.usda.gov/bitstream/10113/8686/1/IND43666733.pdf

                 

                The final step  of  chitin  biosynthesis is  the polymerization of  N-acetylglucosamine

                from  the  activated  substrate  UDP-N-acetylglucosamine,  by  the  enzyme  chitin  synthase (EC 2.4.1.16).  This enzyme has been well studied in fungi  and yeasts (Gooday

                1977)…

                 

                Leighton e t  al.  (1981)  have  proposed that diflubenzuron  acts indirectly  on  chitin synthase  by inhibiting a  proteolytic enzyme  required for its  activation from  the  zymogen form.

                 http://www.publish.csiro.au/?act=view_file&file_id=BI9820491.pdf

                 

                 

                Next to cellulose, chitin is the most important biopolymer in nature. It is produced by numerous species belonging to different taxonomic groups, including fungi, molluscs and

                arthropods. The ability to form chitin strictly depends on the expression of chitin synthase (EC 2.4.1.16),

                 http://jeb.biologists.org/content/210/20/3636.full.pdf

                 

                Lufenuron is a benzoylphenylurea drug that interferes with chitin synthesis. It is used in veterinary medicine as a flea prophylactic product, due to its non-specific inhibitory effect on chitin synthesisprobably related to serine protease inhibition.³

                http://jfm.sagepub.com/content/11/2/91.full.pdf

                 

                 

                REASONS NOT TO USE THIS ARE TOO STRONG IN MY OPINION. 

                 

                 

                An unexpected result of lufenuron treatment was the inhibition of midgut epithelial cell differentiation. At concentrations of 0.5 and 1.0 ppm, partially differentiated epithelial cells were seen in the midgut of blood-fed fleas along with fully differentiated cells.

                http://www.ncbi.nlm.nih.gov/pubmed/10467778

                 

                Micrographs of ovaries, from animals treated with lufenuron, showed some space between the follicular epithelium and the oocyte membrane. The in vivo incorporation of radioactive N-acetylglucosamine into chitin was inhibited by the presence of lufenuron.

                http://journals2.scholarsportal.info/details.xqy?uri=/00483575/v98i0001/59_te...

                 

                 
                 
                *********
                The studies above demonstrate that Lufenuron can cause intestinal cell line damage and leaky gut. One benefit of the intestinal cells is that they regenerate quickly, thus demonstrating their ability to heal and restore the intestinal barrier. Lufenuron has the ability to block this regeneration. It's role in serine protease inhibition could lead to chronic inflammatory conditions, food allergies, autoimmune diseases, etc. 
                Lufenuron can also interfere with absorption of N-Acetylglucosamine, necessary for the formation of the cell walls in many beneficial bacteria. 
                **********
                 

                Disturbance of the epithelial barrier and epithelial transport processes is often discussed to be a major factor in the pathogenesis of intestinal inflammation and inflammatory bowel disease. Increased permeability of the epithelial barrier in ulcerative colitis was first reported in 1973 [11]. 

                How Bacteria-Induced Apoptosis of Intestinal Epithelial Cells Contributes to Mucosal Inflammation

                http://www.hindawi.com/journals/iji/2010/574568/

                 

                The intestinal epithelium provides a critical protective barrier against enteric pathogens, food antigens, and physiochemical stresses caused by digestive and microbial products, and yet must be selectively permeable to beneficial nutrients and fluids. Tightly regulated control of barrier function and integrity is critical, as the pathogenesis of intestinal diseases such as Crohn's disease, ulcerative colitis, inflammatory bowel diseases (IBD), and autoimmune diseases are linked to intestinal barrier dysfunction and increased intestinal permeability (1). The intestinal epithelium is a single layer of linked columnar epithelial cells that regulates, through the paracellular pathway, the selective passage of ions, fluid, and macromolecules from the intestinal lumen into the underlying tissues. 

                 

                The intestinal epithelium serves as a major protective barrier between the mammalian host and the external environment. Here we show that the transmembrane serine protease matriptase plays a pivotol role in the formation and integrity of the intestinal epithelial barrierSt14 hypomorphic mice, which have a 100-fold reduction in intestinal matriptase mRNA levels, display a 35% reduction in intestinal transepithelial electrical resistance (TEER). Matriptase is expressed during intestinal epithelial differentiation and colocalizes with E-cadherin to apical junctionalcomplexes (AJC) in differentiated polarized Caco-2 monolayers. Inhibition of matriptase activity using a specific peptide inhibitor or by knockdown of matriptase by siRNA disrupts the development of TEER in barrier-forming Caco-2 monolayers and increases paracellular permeability to macromolecular FITC-dextran. Loss of matriptase was associated with enhanced expression and incorporation of the permeability-associated, “leaky” tight junction protein claudin-2 at intercellular junctions.  These results support a key role for matriptase in regulating intestinal epithelial barrier competence, and suggest an intriguing link between pericellular serine protease activity and tight junction assembly in polarized epithelia.

                http://www.pnas.org/content/107/9/4200.full

                 

                 

                “Mechanisms terminating the short physiological life cycle of epithelial cells are supposed to have an impact on these essential functions and have influence on inflammatory reactions in the intestinal mucosa. A disturbance of the epithelial barrier is thought to be a major factor in the pathogenesis of inflammatory bowel disease.

                Disturbance of the epithelial barrier and epithelial transport processes is often discussed to be a major factor in the pathogenesis of intestinal inflammation and inflammatory bowel disease.”

                http://www.hindawi.com/journals/iji/2010/574568/

                 

                 

                ***********

                One website that sells lufenuron has pictures of inflammatory skin conditions that responded to lufenuron treatment. A deficiency of serine protease inhibitors can play a role in creating such inflammatory skin conditions. The website implies that the healing seen in the pictures was created by lufenuron's anti-fungal affect against candida. It is much more likely that this was due to its serine protease inhibition effect. I've talked frequently about how people misinterpret what they see and notice. This would be a classic example.

                 

                Lufenuron has demonstrated the ability to damage intestinal cells and intestinal cell junctions. Intestinal cells play a critical role in the maintenance of the homeostasis of the intestinal tract. Lufenuron can also interfere with the structure of healthy intestinal bacteria. It has demonstrated a possible role in affecting candida fungal growth. The goal of any approach in restoring balance to the intestinal flora, immune responses, and candida overgrowth, should not also present known risks to the body. Based on this, I would never recommend lufenuron.

                 
                Printer-friendly version of this page
                Email this message to a friend
                Bookmark this page/Add to Favorites or press Ctrl+D
                Alert Webmaster & Moderators
                 Already alerted!
                How do you feel about this message?     Like     Dislike       Hide this question
                Find & Order All Messages Posted by Dr.Jeff
                by
                DISCLAIMER




                Medianet Ads











 
Medianet Ads


 

Donate to CureZone


Terms of Service - Privacy Policy - Spam Policy - Disclaimer - Guidelines & Rules - Forum Trolls

CureZone Newsletter is distributed in partnership with www.netatlantic.com


Contact Us - About - Sponsors - Stats

Copyright 1999 - 2014  curezone.org